PHASE-I AND PHARMACOLOGICAL STUDY OF ACIVICIN BY 24-HOUR CONTINUOUS INFUSION

被引：0
|
作者：
WEISS, GR
MCGOVREN, JP
SCHADE, D
KUFE, DW
机构：
[1] HARVARD UNIV, SCH MED, SIDNEY FARBER CANC INST, DIV MED, BOSTON, MA 02115 USA
[2] UPJOHN CO, KALAMAZOO, MI 49001 USA
来源：
CANCER RESEARCH | 1982年 / 42卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3892 / 3895
页数：4
相关论文
共 50 条
  • [31] Phase I study of the new camptothecin analogue DX-8951F administered by 24-hour continuous infusion
    Hoff, PM
    Lassere, Y
    Royce, M
    Matei, C
    Slaughter, M
    Medgyesy, D
    Lee, J
    Coyle, J
    De Jager, RL
    Pazdur, R
    ANNALS OF ONCOLOGY, 1998, 9 : 65 - 65
  • [32] A PHASE-I STUDY OF ACIVICIN (AT-125)
    OHNUMA, T
    SRIDHAR, K
    GOLDSMITH, M
    BRUCKNER, H
    CHAHINIAN, AP
    HOLLAND, JF
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 382 - 382
  • [33] PHASE-I STUDY OF BISANTRENE BY 72-HOUR INFUSION
    KOVACH, JS
    KVOLS, LK
    POWIS, G
    INVESTIGATIONAL NEW DRUGS, 1984, 2 (01) : 109 - 109
  • [34] PHASE-I TRIAL OF TAXOL GIVEN AS A 24-HOUR INFUSION EVERY 21 DAYS - RESPONSES OBSERVED IN METASTATIC MELANOMA
    WIERNIK, PH
    SCHWARTZ, EL
    EINZIG, A
    STRAUMAN, JJ
    LIPTON, RB
    DUTCHER, JP
    JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (08) : 1232 - 1239
  • [35] PHASE-I PHARMACOKINETIC STUDY OF THIOGUANINE ADMINISTERED AS A 48-HOUR CONTINUOUS INTRAPERITONEAL INFUSION
    ZIMM, S
    CLEARY, SM
    HORTON, CN
    HOWELL, SB
    JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (04) : 696 - 700
  • [36] Phase I study of Ixabepilone administered as a 24-hour infusion in patients with advanced solid malignancies
    Tan, Antoinette R.
    Mekhail, Tarek
    Edelman, Martin J.
    Rubin, Eric H.
    Iacono, Lisa C.
    Linowski, Greg
    Trifan, Ovid C.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3578S - 3578S
  • [37] PHASE-I STUDY OF CONTINUOUS-INFUSION CISPLATIN
    POSNER, MR
    SKARIN, AT
    CLARK, J
    ERVIN, TJ
    CANCER TREATMENT REPORTS, 1986, 70 (07): : 847 - 850
  • [38] A phase I Pharmacologic and pharmacodynamic study of pyrazoloacridine given as a weekly 24-hour continuous intravenous infusion in adult cancer patients
    Grem, JL
    Harold, N
    Keith, B
    Chen, AP
    Kao, V
    Takimoto, CH
    Hamilton, JM
    Pang, J
    Pace, M
    Jasser, GB
    Quinn, MG
    Monahan, BP
    CLINICAL CANCER RESEARCH, 2002, 8 (07) : 2149 - 2156
  • [39] Phase I clinical and pharmacokinetic study of topotecan administered by a 24-hour continuous infusion (vol 13, pg 1768, 1995)
    vanWarmerdam
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (02) : 689 - 689
  • [40] PROLONGED INFUSION OF HEXAMETHYLENE BISACETAMIDE - A PHASE-I AND PHARMACOLOGICAL STUDY
    ROWINSKY, EK
    ETTINGER, DS
    MCGUIRE, WP
    NOE, DA
    GROCHOW, LB
    DONEHOWER, RC
    CANCER RESEARCH, 1987, 47 (21) : 5788 - 5795
12345